Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: Role of KATP Channel Loss in Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial explores the role of loss of ATP-sensitive potassium (KATP) channels in obesity and Type 2 diabetes and is currently recruiting at Washingto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Obesity and Type 2 Diabetes | NA | Status: RECRUITING